Pacer Advisors Inc. Has $12.72 Million Holdings in Danaher Co. (NYSE:DHR)

Pacer Advisors Inc. lessened its position in Danaher Co. (NYSE:DHR) by 4.8% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 50,890 shares of the conglomerate’s stock after selling 2,576 shares during the period. Pacer Advisors Inc.’s holdings in Danaher were worth $12,715,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Cape Investment Advisory Inc. acquired a new stake in Danaher in the fourth quarter valued at approximately $25,000. Tsfg LLC grew its stake in Danaher by 733.3% in the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 88 shares during the period. CarsonAllaria Wealth Management Ltd. acquired a new stake in Danaher in the second quarter valued at approximately $25,000. nVerses Capital LLC acquired a new stake in Danaher in the second quarter valued at approximately $25,000. Finally, Redmont Wealth Advisors LLC acquired a new stake in Danaher in the first quarter valued at approximately $30,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, CFO Matthew Mcgrew sold 16,172 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $279.84, for a total transaction of $4,525,572.48. Following the sale, the chief financial officer now directly owns 29,407 shares in the company, valued at approximately $8,229,254.88. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CFO Matthew Mcgrew sold 16,172 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $279.84, for a total transaction of $4,525,572.48. Following the sale, the chief financial officer now directly owns 29,407 shares in the company, valued at approximately $8,229,254.88. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Rainer Blair sold 9,007 shares of the business’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total value of $2,521,960.00. Following the sale, the chief executive officer now owns 97,983 shares in the company, valued at $27,435,240. The disclosure for this sale can be found here. In the last three months, insiders have sold 39,659 shares of company stock worth $11,042,433. 11.10% of the stock is owned by company insiders.

Danaher Stock Performance

Shares of DHR opened at $272.63 on Monday. The firm has a market cap of $201.93 billion, a PE ratio of 46.21, a PEG ratio of 4.48 and a beta of 0.83. The stock’s fifty day moving average price is $267.62 and its two-hundred day moving average price is $257.19. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.15. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The business’s revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the company posted $2.05 earnings per share. On average, equities research analysts forecast that Danaher Co. will post 7.59 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, September 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.40%. Danaher’s payout ratio is 18.31%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on DHR shares. Barclays lifted their target price on Danaher from $270.00 to $285.00 and gave the company an “equal weight” rating in a research report on Wednesday, July 24th. Jefferies Financial Group started coverage on Danaher in a research report on Monday, June 3rd. They set a “buy” rating and a $295.00 target price on the stock. Wells Fargo & Company started coverage on Danaher in a research report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 target price on the stock. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research report on Tuesday, June 25th. Finally, TD Cowen lifted their target price on Danaher from $290.00 to $310.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th. Seven research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $278.94.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.